Adjunctive therapy for partial onset seizures in accordance with NICE NG217
Pack |
---|
14 tablet |
Pack |
---|
56 tablet |
Pack |
---|
56 tablet |
Pack |
---|
56 tablet |
Pack |
---|
56 tablet |
Pack |
---|
300 ml |
Pack |
---|
1 ml |
100 ml |
Pack |
---|
100 ml |
GREEN - first choice for trigeminal neuralgia
PURPLE - epilepsy (as per NICE NG217) and prophylaxis of bipolar disorder unresponsive to lithium (Tegretol in Brighton & Hove and Crawley, Horsham and Mid Sussex)
Oral liquid reserved for those with swallowing difficulties or specific clinical need.
Pack |
---|
500 tablet |
84 tablet |
28 tablet |
56 tablet |
Pack |
---|
84 tablet |
500 tablet |
28 tablet |
56 tablet |
100 tablet |
Pack |
---|
100 tablet |
28 tablet |
56 tablet |
Pack |
---|
56 tablet |
50 tablet |
30 tablet |
60 tablet |
100 tablet |
Pack |
---|
56 tablet |
30 tablet |
50 tablet |
60 tablet |
Pack |
---|
5 suppository |
Pack |
---|
5 suppository |
Pack |
---|
300 ml |
50 ml |
250 ml |
Pack |
---|
84 tablet (6 x 14 tablets) |
Pack |
---|
84 tablet (6 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
Pack |
---|
56 tablet (4 x 14 tablets) |
To be initiated in a tertiary epilepsy centre for focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has not been adequately controlled with at least 2 antiseizure medicines
Pack |
---|
28 tablet |
Pack |
---|
14 tablet |
Pack |
---|
14 tablet |
28 tablet |
Pack |
---|
14 tablet |
28 tablet |
Pack |
---|
14 tablet |
28 tablet |
Pack |
---|
14 tablet |
28 tablet |
Pack |
---|
30 tablet |
60 tablet |
20 tablet |
50 tablet |
Pack |
---|
150 ml |
250 ml |
Pack |
---|
150 ml |
250 ml |
Pack |
---|
100 tablet |
150 tablet |
60 tablet |
105 tablet |
Pack |
---|
100 tablet |
Pack |
---|
100 tablet |
60 tablet |
105 tablet |
Pack |
---|
150 ml |
Pack |
---|
150 ml |
PURPLE - Brighton & Hove under specialist palliative care advice
RED - West Sussex and East Sussex
Pack |
---|
5 ampoule |
Syrup reserved for paediatric use and those with swallowing difficulties or specific clinical need
Pack |
---|
56 capsule |
112 capsule |
50 capsule |
60 capsule |
Pack |
---|
200 ml |
Pack |
---|
125 ml |
250 ml |
200 ml |
GREEN - unlicensed use in migraines
PURPLE - epilepsies as per NG217Â
Oral solution reserved for paediatric use and those with swallowing difficulties or specific clinical need
Pack |
---|
100 capsule |
50 capsule |
90 capsule |
Pack |
---|
100 capsule |
40 capsule |
50 capsule |
90 capsule |
Pack |
---|
100 capsule |
30 capsule |
50 capsule |
90 capsule |
Pack |
---|
100 tablet |
10 tablet |
Pack |
---|
100 tablet |
Pack |
---|
150 ml |
Syrup reserved for paediatric use and those with swallowing difficulties or specific clinical need
Pack |
---|
14 tablet |
56 tablet |
Pack |
---|
56 tablet |
14 tablet |
Pack |
---|
14 tablet |
56 tablet |
Pack |
---|
56 tablet |
Pack |
---|
200 ml |
Exposure to sodium-containing formulations of effervescent, dispersible and soluble medicines associated with significantly increased odds of adverse cardiovascular events compared with standard formulations of the same drug. Sodium-containing formulations should be prescribed with caution only if the perceived benefits outweigh these risks
Pack |
---|
21 tablet |
42 tablet |
56 tablet |
30 tablet |
14 tablet |
60 tablet |
28 tablet |
Pack |
---|
56 tablet |
42 tablet |
30 tablet |
14 tablet |
28 tablet |
84 tablet |
Pack |
---|
56 tablet |
30 tablet |
28 tablet |
60 tablet |
Pack |
---|
56 tablet |
30 tablet |
28 tablet |
60 tablet |
Oral solution reserved for paediatric use and those with swallowing difficulties or specific clinical need
Pack |
---|
60 tablet |
100 tablet |
30 tablet |
50 tablet |
Pack |
---|
60 tablet |
100 tablet |
50 tablet |
30 tablet |
200 tablet |
Pack |
---|
60 tablet |
50 tablet |
Pack |
---|
60 tablet |
30 tablet |
Pack |
---|
300 ml |
150 ml |
Pack |
---|
10 ampoule |
Pack |
---|
10 vial |
1 vial |
Pack |
---|
50 tablet |
Pack |
---|
50 tablet |
Pack |
---|
50 tablet |
100 tablet |
Pack |
---|
250 ml |
Pack |
---|
7 tablet |
28 tablet |
Pack |
---|
28 tablet |
Pack |
---|
28 tablet |
Pack |
---|
28 tablet |
Pack |
---|
28 tablet |
Pack |
---|
28 tablet |
Please note the Elixir is a Category 1 anti-epileptic so patients should be maintained on specific brand (but choice of brand on formulary is unrestricted)
Pack |
---|
1000 tablet |
28 tablet |
Pack |
---|
28 tablet |
Pack |
---|
28 tablet |
250 tablet |
Pack |
---|
500 ml |
PURPLE - 30mg/mL injection and 60mg/mL injection for use as an anxiolytic/hypnotic
RED - 200mg/mL injectionÂ
Pack |
---|
10 ampoule |
Pack |
---|
10 ampoule |
Pack |
---|
10 ampoule |
PURPLE - treatment of epilepsies
RED - trigeminal neuralgia only
Pack |
---|
28 capsule |
Pack |
---|
28 capsule |
Pack |
---|
84 capsule |
100 capsule |
Pack |
---|
28 capsule |
Pack |
---|
1000 tablet |
28 tablet |
100 tablet |
Pack |
---|
500 ml |
250 ml |
PURPLE - treatment in epilepsies
Solution for use in patients who cannot open pregabalin capsules or have swallowing difficulties. Patients should be reviewed if liquid is no longer needed and switched back to capsules if appropriate
High abuse potential
Use twice daily dosing as flat pricing structure
Pack |
---|
56 capsule |
84 capsule |
100 capsule |
14 capsule |
Pack |
---|
84 capsule |
56 capsule |
21 capsule |
Pack |
---|
56 capsule |
14 capsule |
100 capsule |
250 capsule |
Pack |
---|
84 capsule |
21 capsule |
56 capsule |
Pack |
---|
56 capsule |
14 capsule |
100 capsule |
250 capsule |
Pack |
---|
84 capsule |
21 capsule |
56 capsule |
Pack |
---|
56 capsule |
Pack |
---|
56 capsule |
Pack |
---|
473 ml |
500 ml |
Pack |
---|
100 tablet |
Pack |
---|
100 tablet |
60 tablet |
90 tablet |
30 tablet |
Pack |
---|
10 tablet |
Pack |
---|
60 tablet |
Pack |
---|
60 tablet |
Pack |
---|
460 ml |
Mixed formulary colour coding:
AMBER (shared care): in people of child bearing potential
PURPLE: for people of non child bearing potential
For use in epilepsy and as a mood stabiliser
Pack |
---|
100 tablet |
30 tablet |
Pack |
---|
100 tablet |
30 tablet |
Pack |
---|
100 tablet |
30 tablet |
Pack |
---|
100 capsule |
30 capsule |
Pack |
---|
100 capsule |
30 capsule |
Pack |
---|
100 tablet |
30 tablet |
Pack |
---|
100 tablet |
30 tablet |
Pack |
---|
100 tablet |
30 tablet |
Pack |
---|
30 sachet |
Pack |
---|
30 sachet |
Pack |
---|
30 sachet |
Pack |
---|
100 sachet |
30 sachet |
Pack |
---|
30 sachet |
Pack |
---|
100 sachet |
30 sachet |
Pack |
---|
300 ml |
Pack |
---|
300 ml |
Pack |
---|
60 capsule |
Pack |
---|
60 capsule |
Pack |
---|
60 sachet |
Pack |
---|
60 sachet |
Pack |
---|
100 tablet |
50 tablet |
Pack |
---|
100 tablet |
50 tablet |
Pack |
---|
100 tablet |
50 tablet |
GREEN - prophylactic treatment of adult migraine
PURPLE - treatment in epilepsies
Topiramate is now contraindicated in pregnancy and in women of childbearing potential unless the conditions of a Pregnancy Prevention Programme are fulfilled. This follows a review by the MHRA which concluded that the use of topiramate during pregnancy is associated with significant harm to the unborn child. Harms included a higher risk of congenital malformation, low birth weight and a potential increased risk of intellectual disability, autistic spectrum disorder and attention deficit hyperactivity disorder in children of mothers taking topiramate during pregnancy. Please see latest MHRA information for advice.
Pack |
---|
60 capsule |
Pack |
---|
60 capsule |
Pack |
---|
60 capsule |
Pack |
---|
60 tablet |
28 tablet |
Pack |
---|
60 tablet |
28 tablet |
56 tablet |
Pack |
---|
60 tablet |
28 tablet |
56 tablet |
Pack |
---|
60 tablet |
28 tablet |
56 tablet |
Pack |
---|
14 capsule |
56 capsule |
Pack |
---|
56 capsule |
28 capsule |
Pack |
---|
56 capsule |
65 capsule |